Skip to content

Avanos Medical AVNS Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

IAR
Integra LifeSciencesIART
-$90K+81.8%
Novanta logo
NovantaNOVT
$248K-94.3%
Globus Medical logo
Globus MedicalGMED
-$2.45M+6.3%
Enovis logo
EnovisENOV
$75K-85.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
-$573K-267%
Corvel logo
CorvelCRVL
-$698K-111%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's gain/loss on asset sales?
Avanos Medical (AVNS) reported gain/loss on asset sales of -$100K in Q1 2026.
How has Avanos Medical's gain/loss on asset sales changed year-over-year?
Avanos Medical's gain/loss on asset sales increased by 50.0% year-over-year, from -$200K to -$100K.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.